Convalescent Plasma is the liquid portion of the blood collected from people who have recovered from COVID-19. After fighting the SARS-Cov-2 coronavirus, their plasma may now contain high levels of antibodies that could help someone else fight COVID-19.
A number of studies are testing plasma in hospitalized patients, but what about people who are not hospitalized? A group of medical schools and clinical researchers across the United States, organized by Johns Hopkins University, are now conducting what are called outpatient trials. They want to learn if plasma can reduce the spread of the virus and lower the number of people who get hospitalized with COVID-19.
Houston’s official “Fitness Czar”, Samir Becic, was contacted by Johns Hopkins University to spread awareness about the convalescent plasma trials now being conducted in Houston. He finds the cause noble and jumped at the opportunity to positively contribute to helping those affected by COVID-19. Click here to find out more and register.
Houstonians, let's fight back against #COVID19! @JohnsHopkins, @Baylor and @UTHealth Houston are studying the impact of #plasma on #coronavirus. If you’ve been exposed or diagnosed, find out more about the #clinicaltrial at https://t.co/XEfi1e7YBG or 888-506-1199.
— Samir Becic (@SamirBecic) February 9, 2021
